Synopsis

As more SCS systems that provide multiple neurostimulation approaches continue to become available, it will be necessary to evaluate usage of these devices and associated clinical outcomes. In this study, long-term outcomes were assessed in patients using a new SCS system designed to customize SCS using combination therapy, waveform automation, and a device algorithm engineered for manipulatable control of stimulation field shape. Twenty-three percent of all patients reported being pain free (NRS = 0) at last follow-up. Given the variability of experience associated with chronic pain, the SCS-implanted patient population may particularly benefit from devices that enable individualized treatment customization.

Disclosures

Mr. Hammond reports personal fees from Orthomicrospine and personal fees from Boston Scientific.
Dr. Pyles has received speaker honoraria from and is a consultant for Boston Scientific.
Dr. Waghmarae is a consultant for Boston Scientific. Dr. North is a consultant for Boston Scientific.
Dr. Berg is a consultant for Boston Scientific.
Drs. Metzger and Washabaugh report no relevant conflicts of interest.
Ms. Jain and Ms. Pei are salaried employees of Boston Scientific.
This study was sponsored by Boston Scientific.

Roshini Jain MS

Clinical Research, Director, Boston Scientific Neuromodulation

Appearances